CDK inhibitor Purvalanol B, Purity ≥98%

Cat. No.: X24-05-ZQ741

CDK inhibitor Purvalanol B, Purity ≥98%

Synonym: 212844-54-7; NG 95; CDK inhibitor

  • CAS Number: 212844-54-7
  • Compound CID: 448991
Product Size
10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
Purvalanol B, soluble in DMSO, water and ethanol, is an CDK kinase inhibitor that disrupts cell division processes. It targets cdc2/cyclin B, cdk2/cyclin A, CDK2/cyclinE, and CDK5/p35.
Molecular Weight
432.91
Molecular Formula
C20H25ClN6O3
Targets
cdc2/cyclin B: 6 nM; cdk2/cyclin A: 6 nM; CDK2/cyclinE: 9 nM; CDK5/p35: 6 nM
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 84 mg/mL (194.04 mM); Water: <1 mg/mL; Ethanol: <1 mg/mL
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
Purvalanol B can be used to explore CDK inhibition and its effects on cell cycle arrest and apoptosis.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.